A detailed history of Palo Alto Investors LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 604,260 shares of BLUE stock, worth $211,491. This represents 0.04% of its overall portfolio holdings.

Number of Shares
604,260
Previous 4,633,351 86.96%
Holding current value
$211,491
Previous $4.54 Million 93.08%
% of portfolio
0.04%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.47 - $1.35 $1.89 Million - $5.44 Million
-4,029,091 Reduced 86.96%
604,260 $314,000
Q2 2024

Aug 14, 2024

BUY
$0.85 - $1.26 $62,203 - $92,206
73,180 Added 1.6%
4,633,351 $4.54 Million
Q1 2024

May 15, 2024

BUY
$0.91 - $1.75 $1.12 Million - $2.15 Million
1,226,838 Added 36.81%
4,560,171 $5.84 Million
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $4.4 Million - $16.1 Million
3,333,333 New
3,333,333 $4.6 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.